You are here: Home » News-IANS » Business-Economy
Business Standard

Second US lawsuit brought against Aurobindo Pharma

IANS  |  Mumbai 

on Tuesday informed stock exchanges that the company, as well as other firms in the US industry, are facing a second lawsuit for violation of antitrust laws.

This lawsuit, filed on May 10, was the second after the one filed in December 2016.

"US states filed a second lawsuit in similarly alleging that Aurobindo and other companies in the US industry had violated antitrust laws by fixing prices and allocating customers (the 'Second Action')," said in a regulatory filing.

The company said the "Second Action" includes additional parties and additional products which were not referenced in the "First Action" .

In December 2016, the Attorney (AG) of the State of along with the Attorneys' of various other US states filed a lawsuit in alleging that Aurobindo and other companies in the US industry had violated antitrust laws by fixing prices and allocating customers - the "Action".

"On 18 June 2018, an amended complaint was filed in the Action. Aurobindo has denied all the relevant accusations in the Action and is vigorously defending against the matter," the company said.

The statement said the company is reviewing the "Second State AG Action and expect that we will be filing papers with the in due course denying each of the relevant accusations."

Aurobindo does not, at this juncture, anticipate that these matters will have a material impact on the its operations or business results, it added.

--IANS

ravi/sn/bc

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 14 2019. 13:02 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU